Alejandro Berlin, MD, MSc

Clinician-Scientist, Vice Chair of Research
Princess Margaret Cancer Centre
Toronto, ON, Canada

Dr. Ale Berlin is a staff clinician-scientist radiation oncologist at the Princess Margaret Cancer Center (Toronto, Canada). He completed his training in Chile, Israel, and Canada. His clinical practice focuses on the discovery and clinical evaluation of novel therapeutics capitalizing on genomic characterization genitourinary malignancies, molecular and MR imaging, and high-precision radiotherapy techniques. Dr. Berlin is a PI of the NRG GU010 study investigating the use of clinicogenomic risk stratification for treatment individualization in men with localized prostate cancer. Dr. Berlin also leads a clinical initiative quantifying the human and machine performance during the clinical deployment of an in-house developed AI radiotherapy planning method for prostate cancer.

Disclosure information not submitted.

Presentation(s):

• Showdown Debate I | AI IS READY FOR CLINICAL DECISION SUPPORT

  Friday, March 21, 2025
  8:00 AM – 9:00 AM MST